Allostero

Allostero is a term used in biology and pharmacology to describe a type of regulation where the binding of a ligand to a receptor or enzyme alters the affinity of that receptor or enzyme for another ligand. This phenomenon is distinct from autostero, where the binding of a ligand to a receptor or enzyme enhances the affinity of that receptor or enzyme for the same ligand. Allostero is a key concept in understanding the function of many biological molecules, including enzymes, hormones, and neurotransmitters.

The term "allostero" was coined by British physiologist John Carew Eccles in 1957. He used it to describe the regulation of the neuromuscular junction, where the binding of acetylcholine to its receptor alters the affinity of the receptor for calcium ions. This type of regulation is crucial for the efficient transmission of nerve impulses across the synapse.

Allostero regulation can be positive or negative. In positive allostero, the binding of a ligand increases the affinity of the receptor or enzyme for another ligand. In negative allostero, the binding of a ligand decreases the affinity of the receptor or enzyme for another ligand. This dual nature of allostero regulation allows for fine-tuned control of biological processes.

Allostero regulation is not limited to the neuromuscular junction. It is also involved in the regulation of many other biological processes, including enzyme catalysis, hormone action, and neurotransmission. For example, in the case of enzymes, allostero regulation can enhance or inhibit the activity of the enzyme, depending on the specific ligands involved.

In summary, allostero is a fundamental concept in biology and pharmacology that describes the regulation of biological molecules by the binding of ligands. It plays a crucial role in the control of many biological processes and is a key area of study in the fields of pharmacology and molecular biology.